|Bid||11.70 x 2900|
|Ask||12.34 x 3000|
|Day's Range||11.82 - 12.28|
|52 Week Range||10.10 - 22.40|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 03, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||33.00|
Right now, markets are giving investors opposing trends simultaneously. The S&P and NASDAQ have posted strong year-to-date gains. At the same time, however, Wall Street strategists are growing more concerned that a slowing U.S. economy could derail the stock market’s record run. It’s an environment full of risk, and so risk-friendly investors are finding plenty of options – including short trading. Short trading is betting on the risks to play out; it’s buying into a position using borrowed shar
One thing we could say about the analysts on Heron Therapeutics, Inc. ( NASDAQ:HRTX ) - they aren't optimistic, having...
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -5.08% and -21.08%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?